gliclazide and fructosamine

gliclazide has been researched along with fructosamine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnett, AH; Florkowski, CM; Jennings, PE; Jones, AF; Le Guen, C; Lunec, J; O'Donnell, MJ; Richardson, MR	1
Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW	1
Kruseman, AC; Menheere, PP; Müller, PG; Nijst, L; Sels, JP; Wolffenbuttel, BH	1
Hammersley, MS; Holman, RR; Manley, SE; Meyer, LC; Morris, RJ; Turner, RC	1
Gomis, R; Jones, NP; Patwardhan, RN; Squatrito, S; Wolffenbuttel, BH	1
Chabraoui, L; Chebraoui, L; Chraibi, A; El Guessabi, L; Fellat, S; Israili, ZH; Lyoussi, B; M'guil, M; Ragala, MA	1
Cheng, H; Fu, Z; Li, Y; Ran, J; Shen, J; Wang, M; Xu, L; Yan, L; Zhang, Y	1

Trials

5 trial(s) available for gliclazide and fructosamine

Article	Year
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes care, 1995, Volume: 18, Issue:3 Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides	1995
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM. European journal of clinical pharmacology, 1993, Volume: 45, Issue:2 Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Piperidines; Tolbutamide	1993
The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:12 Suppl 1 Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; England; Fasting; Female; France; Fructosamine; Gliclazide; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Life Style; Male; Middle Aged; Patient Selection; Risk Factors; Sulfonylurea Compounds; Time Factors; World Health Organization	1997
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients. Diabetic medicine : a journal of the British Diabetic Association, 2000, Volume: 17, Issue:1 Topics: Adult; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Triglycerides	2000
Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus. Diabetes research and clinical practice, 2010, Volume: 88, Issue:1 Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Carbamates; Chi-Square Distribution; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipids; Male; Middle Aged; Oxidative Stress; Piperidines; Postprandial Period; Sulfonylurea Compounds; Treatment Outcome	2010

Other Studies

2 other study(ies) available for gliclazide and fructosamine

Article	Year
Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus. Diabetes research (Edinburgh, Scotland), 1988, Volume: 9, Issue:2 Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Immunoglobulin G; Lipid Peroxides; Male; Platelet Aggregation; Sulfonylurea Compounds; Thromboxane B2	1988
Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control? Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:5 Topics: Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islam; Liver Function Tests; Male; Middle Aged; Morocco; Patient Education as Topic; Religion and Medicine; Risk Factors; Treatment Outcome; Triglycerides	2008

Article

Year

Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.

Diabetes research (Edinburgh, Scotland), 1988, Volume: 9, Issue:2

Topics: Aged; Blood Proteins; Diabetes Mellitus, Type 2; Female; Fructosamine; Gliclazide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Immunoglobulin G; Lipid Peroxides; Male; Platelet Aggregation; Sulfonylurea Compounds; Thromboxane B2

1988

Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control?

Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:5

Topics: Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fasting; Female; Fructosamine; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islam; Liver Function Tests; Male; Middle Aged; Morocco; Patient Education as Topic; Religion and Medicine; Risk Factors; Treatment Outcome; Triglycerides

2008